Chloropyramine
正在补全数据,稍后刷新页面可查看最新内容
59-32-5CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1ICKFFNBDFNZJSX-UHFFFAOYSA-NN'-[(4-chlorophenyl)methyl]-N,N-dimethyl-N'-(2-pyridinyl)ethane-1,2-diamine is an aminopyridine.
59-32-5DTXSID50207729CHEMBL1194287、CHEMBL550011CHEBI:94767< 25 °C
60 °C
安全信息仅供参考,不能替代供应商安全技术说明书(SDS)、适用法规与专业评估。
Danger
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P233, P260, P261, P264, P264+P265, P270, P271, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
R - Respiratory system
D - Dermatologicals
QD - Dermatologicals
QR - Respiratory system
Chlorpyramine is a competitive reversible H1 receptor antagonist. This inhibits vasodilation, increases in vascular permeability, and tissue edema associated with histamine release. In addition, chloropyramine has some anticholinergic properties. These effects, along with its ability to pass through the blood-brain barrier lead to side effects such as drowsiness, weakness, vertigo, fatigue, dryness in the mouth, constipation, and rarely - visual disturbances and increase of intraocular pressure.
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.
概述氯吡拉敏 是竞争性可逆 H1 受体拮抗剂。Chloropyramine 在乳腺癌中也具有抗肿瘤活性。Chloropyramine 可用于过敏性疾病的研究,如结膜炎和支气管哮喘。